Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma Sachin Wani, Gary Falk, Matthew.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Esophageal Adenocarcinoma

Sachin Wani, Dayna Early, Steve Edmundowicz, Prateek Sharma

The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Saurabh Dawra, Vishal Sharma, Usha Dutta

How to Manage a Barrett's Esophagus Patient With Low-Grade Dysplasia

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

A Model to Determine 3-Month Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure Ming–Hua Zheng, Ke–Qing Shi, Yu–Chen Fan, Hai.

Volume 152, Issue 5, Pages (April 2017)

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus Amitabh Chak, Navtej S. Buttar, Nathan.

A Model to Determine Absolute Risk for Esophageal Adenocarcinoma

Endoscopic Ultrasound Does Not Accurately Stage Early Adenocarcinoma or High- Grade Dysplasia of the Esophagus Patrick E. Young, Andrew B. Gentry, Ruben.

Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer Christine Kestens, G.

Issue Highlights Clinical Gastroenterology and Hepatology

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Association Between Length of Barrett's Esophagus and Risk of High-grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia Rajeswari Anaparthy,

Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald

Issue Highlights Clinical Gastroenterology and Hepatology

Patrick B. Allen, Paul J. Kettle, Inder Mainie

Prateek Sharma, MD, Sachin Wani, MD, Amit Rastogi, MD

Volume 141, Issue 4, Pages e1 (October 2011)

Volume 143, Issue 3, Pages e1 (September 2012)

Esophageal Adenocarcinoma 10 Years After Surgical Resection of Barrett’s Esophagus: Unusual Presentation as Subepithelial Tumor Andreas Probst, Tina.

Bisphosphonates Are Associated With Reduced Risk of Colorectal Cancer: A Systematic Review and Meta-analysis Siddharth Singh, Abha Goyal Singh, Mohammad.

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A

Alan J. Wigg, Rosemary McCormick, Rachel Wundke, Richard J. Woodman

Endoscopic Therapy for Barrett's Esophagus

Aaron P. Thrift, PhD Clinical Gastroenterology and Hepatology

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Patrick Hoversten, Fouad Otaki, David A. Katzka

Metastatic Malignant Melanoma of the Gastrointestinal Tract

New Models of Gastroenterology Practice

Ramesh Kumar, Masiullah, Pintu Kumar Singh

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Efficacy, Safety, and Long-term Results of Endoscopic Treatment for Early Stage Adenocarcinoma of the Esophagus With Low-risk sm1 Invasion Hendrik Manner,

Jianguang Ji, Kari Hemminki Clinical Gastroenterology and Hepatology

Adding Triamcinolone to Endoscopic Ultrasound–Guided Celiac Plexus Blockade Does Not Reduce Pain in Patients With Chronic Pancreatitis Tyler Stevens,

Endoscopic Ultrasound-guided Specimen Collection and Evaluation Techniques Affect Diagnostic Accuracy Ji Young Bang, Udayakumar Navaneethan, Muhammad.

Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan,

Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,

Rebecca M. Lovell, Alexander C. Ford

Issue Highlights Clinical Gastroenterology and Hepatology

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Patrick Yachimski, William P. Puricelli, Norman S. Nishioka

Issue Highlights Clinical Gastroenterology and Hepatology

Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States Julian A. Abrams, Robert C. Kapel,

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Volume 152, Issue 3, Pages e4 (February 2017)

Volume 145, Issue 3, Pages e1 (September 2013)

Prateek Sharma, Gary W. Falk, Allan P

Barrett’s Esophagus in Women: Demographic Features and Progression to High-Grade Dysplasia and Cancer Gary W. Falk, Prashanthi N. Thota, Joel E. Richter,

Rintaro Hashimoto, Akimichi Chonan

Ajaypal Singh, John D. Christein, Shyam Varadarajulu

Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation Timothy C. Wang, Rhonda F. Souza Clinical.

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus Amitabh Chak, Navtej S. Buttar, Nathan.

Rintaro Hashimoto, Akimichi Chonan

Metastatic Malignant Melanoma of the Gastrointestinal Tract

Persistence of Nondysplastic Barrett’s Esophagus Is Not Protective Against Progression to Adenocarcinoma Rajesh Krishnamoorthi, Guilherme Piovezani Ramos,

Karanprit Singh, Prateek Chapalamadugu, Peter Malet

Presentation transcript:

Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma Sachin Wani, Gary Falk, Matthew Hall, Srinivas Gaddam, Amy Wang, Neil Gupta, Mandeep Singh, Vikas Singh, Keng–Yu Chuang, Vikram Boolchand, Hemanth Gavini, John Kuczynski, Priti Sud, Savio Reddymasu, Ajay Bansal, Amit Rastogi, Sharad C. Mathur, Patrick Young, Brooks Cash, David A. Lieberman, Richard E. Sampliner, Prateek Sharma Clinical Gastroenterology and Hepatology Volume 9, Issue 3, Pages 220-227.e1 (March 2011) DOI: 10.1016/j.cgh.2010.11.008 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Patient flow chart. IM, intestinal metaplasia. Clinical Gastroenterology and Hepatology 2011 9, 220-227.e1DOI: (10.1016/j.cgh.2010.11.008) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Kaplan–Meier curve showing the percentage of patients with NDBE free of EAC. Clinical Gastroenterology and Hepatology 2011 9, 220-227.e1DOI: (10.1016/j.cgh.2010.11.008) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Bar diagram highlighting a lower incidence of EAC in larger contemporary studies and a higher incidence in smaller and older cohort studies. Clinical Gastroenterology and Hepatology 2011 9, 220-227.e1DOI: (10.1016/j.cgh.2010.11.008) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 Kaplan–Meier curve showing the percentage of patients with NDBE free of high-grade dysplasia or EAC during follow-up evaluation between females and males. Clinical Gastroenterology and Hepatology 2011 9, 220-227.e1DOI: (10.1016/j.cgh.2010.11.008) Copyright © 2011 AGA Institute Terms and Conditions